Electrophysiology-Guided Genetic Characterisation Maximises Molecular Diagnosis in an Irish Paediatric Inherited Retinal Degeneration Population
- PMID: 35456422
- PMCID: PMC9033125
- DOI: 10.3390/genes13040615
Electrophysiology-Guided Genetic Characterisation Maximises Molecular Diagnosis in an Irish Paediatric Inherited Retinal Degeneration Population
Abstract
Inherited retinal degenerations (IRDs) account for over one third of the underlying causes of blindness in the paediatric population. Patients with IRDs often experience long delays prior to reaching a definitive diagnosis. Children attending a tertiary care paediatric ophthalmology department with phenotypic (i.e., clinical and/or electrophysiologic) evidence suggestive of IRD were contacted for genetic testing during the SARS-CoV-2-19 pandemic using a "telegenetics" approach. Genetic testing approach was panel-based next generation sequencing (351 genes) via a commercial laboratory (Blueprint Genetics, Helsinki, Finland). Of 70 patient samples from 57 pedigrees undergoing genetic testing, a causative genetic variant(s) was detected for 60 patients (85.7%) from 47 (82.5%) pedigrees. Of the 60 genetically resolved IRD patients, 5% (n = 3) are eligible for approved therapies (RPE65) and 38.3% (n = 23) are eligible for clinical trial-based gene therapies including CEP290 (n = 2), CNGA3 (n = 3), CNGB3 (n = 6), RPGR (n = 5) and RS1 (n = 7). The early introduction of genetic testing in the diagnostic/care pathway for children with IRDs is critical for genetic counselling of these families prior to upcoming gene therapy trials. Herein, we describe the pathway used, the clinical and genetic findings, and the therapeutic implications of the first systematic coordinated round of genetic testing of a paediatric IRD cohort in Ireland.
Keywords: Leber congenital amaurosis; achromatopsia; inherited blindness; inherited retinal degenerations; paediatric ophthalmology; panel-based next generation sequencing; retinal dystrophy; retinitis pigmentosa.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Frequency and Genetic Spectrum of Inherited Retinal Dystrophies in a Large Dutch Pediatric Cohort: The RD5000 Consortium.Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):40. doi: 10.1167/iovs.65.10.40. Invest Ophthalmol Vis Sci. 2024. PMID: 39189993 Free PMC article.
-
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.Prog Retin Eye Res. 2024 May;100:101244. doi: 10.1016/j.preteyeres.2024.101244. Epub 2024 Jan 24. Prog Retin Eye Res. 2024. PMID: 38278208 Review.
-
A Description of the Yield of Genetic Reinvestigation in Patients with Inherited Retinal Dystrophies and Previous Inconclusive Genetic Testing.Genes (Basel). 2023 Jul 8;14(7):1413. doi: 10.3390/genes14071413. Genes (Basel). 2023. PMID: 37510321 Free PMC article.
-
Clinical and Genetic Re-Evaluation of Inherited Retinal Degeneration Pedigrees following Initial Negative Findings on Panel-Based Next Generation Sequencing.Int J Mol Sci. 2022 Jan 17;23(2):995. doi: 10.3390/ijms23020995. Int J Mol Sci. 2022. PMID: 35055178 Free PMC article.
-
A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice.Orphanet J Rare Dis. 2023 Jul 31;18(1):223. doi: 10.1186/s13023-023-02798-z. Orphanet J Rare Dis. 2023. PMID: 37525225 Free PMC article. Review.
Cited by
-
IMI-Management and Investigation of High Myopia in Infants and Young Children.Invest Ophthalmol Vis Sci. 2023 May 1;64(6):3. doi: 10.1167/iovs.64.6.3. Invest Ophthalmol Vis Sci. 2023. PMID: 37126360 Free PMC article.
-
Frequency and Genetic Spectrum of Inherited Retinal Dystrophies in a Large Dutch Pediatric Cohort: The RD5000 Consortium.Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):40. doi: 10.1167/iovs.65.10.40. Invest Ophthalmol Vis Sci. 2024. PMID: 39189993 Free PMC article.
-
Expanding the Mutation Spectrum for Inherited Retinal Diseases.Genes (Basel). 2024 Dec 28;16(1):32. doi: 10.3390/genes16010032. Genes (Basel). 2024. PMID: 39858579 Free PMC article.
-
Visualising treatment effects in low-vision settings: proven and potential endpoints for clinical trials of inherited retinal disease therapies.Gene Ther. 2025 Aug 7. doi: 10.1038/s41434-025-00552-7. Online ahead of print. Gene Ther. 2025. PMID: 40775528 Review.
References
-
- Teoh L.J., Solebo A.L., Rahi J.S., Morton C., Allen L., McPhee D., Brennan R., Pennefather P., Kattakayan C., Ramm L., et al. Visual impairment, severe visual impairment, and blindness in children in Britain (BCVIS2): A national observational study. Lancet Child Adolesc. Health. 2021;5:190–200. doi: 10.1016/S2352-4642(20)30366-7. - DOI - PMC - PubMed
-
- Gilbert C., Foster A. Epidemiology of childhood blindness. In: Moore A., editor. Paediatric Ophthalmology. BMJ Books; London, UK: 2000. pp. 1–13.
-
- Taylor D., Hoyt C., editors. Paediatric Ophthalmology and Strabismus. 3rd ed. Blackwell Science Ltd; Oxford, UK: 2003.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous